Diabetic Macular Edema (DME) is a potential complication of DR and currently affects more than 28 million people with diabetes.
The majority (79%) of respondents with diabetes to the Diabetes Retinopathy Barometer Report: Global Findings said their sight problems made everyday activities difficult or impossible.
DME has unique assessment criteria, since it can present in eyes at all levels of DR. Therefore, early screening and detection is crucial in halting and where possible correcting DME. Health practitioners have reported a need for additional training in the diagnosis, treatment and referral of diabetes-related eye disease.
In support of those on the frontline of diabetes eye health, the International Diabetes Federation (IDF) has led a team of experts in the development of the Clinical Practice Recommendations for Managing Diabetic Macular Edema. This is intended to facilitate the work of general practitioners, hospital physicians, and other clinicians working in diabetes-related eye disease management.